Orion Oyj Stock price

Equities

ORNBV

FI0009014377

Pharmaceuticals

Real-time Estimate Tradegate 11:12:55 2024-03-04 am EST 5-day change 1st Jan Change
36.35 EUR -0.71% Intraday chart for Orion Oyj -3.42% -7.16%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 1.36B 1.48B Sales 2025 * 1.46B 1.59B Capitalization 5.14B 5.58B
Net income 2024 * 229M 249M Net income 2025 * 258M 280M EV / Sales 2024 * 3.78 x
Net Debt 2024 * 4.12M 4.47M Net cash position 2025 * 4.14M 4.5M EV / Sales 2025 * 3.51 x
P/E ratio 2024 *
22.5 x
P/E ratio 2025 *
19.9 x
Employees 3,632
Yield 2024 *
4.54%
Yield 2025 *
4.67%
Free-Float 88.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.03%
1 week-2.73%
Current month+0.88%
1 month-13.33%
3 months+0.93%
6 months-2.65%
Current year-6.49%
More quotes
1 week
36.04
Extreme 36.04
37.88
1 month
36.04
Extreme 36.04
44.60
Current year
36.04
Extreme 36.04
45.29
1 year
32.89
Extreme 32.89
47.31
3 years
32.51
Extreme 32.51
55.16
5 years
28.19
Extreme 28.19
55.16
10 years
21.06
Extreme 21.06
58.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 98-12-31
Director of Finance/CFO 63 00-12-31
Chief Tech/Sci/R&D Officer 62 20-05-31
Members of the board TitleAgeSince
Chairman 68 14-03-24
Director/Board Member 63 21-03-24
Director/Board Member 61 17-03-21
More insiders
Date Price Change Volume
24-03-04 36.46 -0.41% 65 558
24-03-01 36.61 +0.58% 196,331
24-02-29 36.4 -1.62% 457,321
24-02-28 37 -0.05% 300,416
24-02-27 37.02 -1.93% 249,837

Delayed Quote Nasdaq Helsinki, March 04, 2024 at 05:43 am EST

More quotes
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (48.3%); - patented prescription products (37.3%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - pharmaceutical ingredients and outsourcing services (7.2%) ; - animal products (7%); - other (0.2%). Net sales are distributed geographically as follows: Finland (30.3%), Scandinavia (13.6%), Europe (34%), North America (8.6%) and other (13.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
36.61 EUR
Average target price
39.9 EUR
Spread / Average Target
+8.99%
Consensus
  1. Stock
  2. Equities
  3. Stock Orion Oyj - Nasdaq Helsinki
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW